SC Agrotech Ltd (526081)

SC Agrotech has shared supplemental illustrative scenarios for its newly launched digital agriculture platform, AgriBridge. The company outlined hypothetical scenarios scaling up to ₹1,000 crore in annual gross merchandise value (GMV) by FY30, which could generate ₹52 crore in revenue at an assumed 5.2% take rate. Management explicitly clarified that these figures are mathematical models and do not represent actual orders, committed capex, sanctioned budgets, or official financial guidance. Currently, no revenue or GMV has been realized from the AgriBridge platform.

• Illustrative GMV roadmap models ₹125 Cr in FY28, ₹500 Cr in FY29, and ₹1,000 Cr in FY30
• Assumed base monetisation rate of 5.2% implies illustrative revenues of ₹6.5 Cr (FY28), ₹26 Cr (FY29), and ₹52 Cr (FY30)
• Hypothetical ₹10 Cr deployment case models ₹1.4 Cr PAT, while a ₹100 Cr deployment case models ₹12.1 Cr PAT at steady state
• Company explicitly stated that these scenarios are not approved budgets, contracted orders, or revenue guidance

SC Agrotech Limited has incorporated a wholly owned subsidiary named SC Orequest Mining Private Limited on November 03, 2026. The new subsidiary is established in the mining sector with an authorized capital of ₹1,00,000 divided into 10,000 equity shares of ₹10 each. SC Agrotech holds 100% initial shareholding via cash/banking channels. This marks a new business vertical outside its core dairy operations.

• Incorporated wholly owned subsidiary 'SC Orequest Mining Private Limited' on November 03, 2026
• Authorized share capital of ₹1,00,000 comprising 10,000 equity shares of ₹10 each
• 100% initial shareholding acquired directly or indirectly by SC Agrotech Ltd
• Target business line is in the mine sector, outside the company's traditional line of business

SC Agrotech has incorporated a wholly owned subsidiary named SC Cropwise Agritech Private Limited on November 04, 2026. The new entity has an authorized share capital of Rs 1,00,000 divided into 10,000 equity shares of Rs 10 each, subscribed 100% via cash. Notably, while SC Agrotech is classified under dairy products with TTM revenue of Rs 124 Cr, the newly formed subsidiary is stated to operate in the pharma business. Given the negligible initial capital, financial impact is immaterial at this stage.

• Incorporated wholly owned subsidiary SC Cropwise Agritech Private Limited on November 04, 2026
• Authorized share capital of Rs 1,00,000 (10,000 equity shares of Rs 10 each)
• Parent SC Agrotech holds 100% initial shareholding via cash/banking channels
• Line of business designated as Pharma business, outside its primary dairy/agri operations

SC Agrotech has scheduled a Board meeting on November 13, 2026, to consider a stock split from face value Rs 10 up to Rs 1 (10-for-1), a bonus issue of up to 4:5, and a potential dividend of up to 100%. The company noted that a 4:5 bonus would capitalise approximately Rs 60.796 Cr against other equity of Rs 61.805 Cr. Furthermore, it highlighted that a 100% dividend (requiring Rs 75.995 Cr) is not established as currently fundable given cash and equivalents of just Rs 0.1317 Cr as of September 30, 2026.

• Board meeting scheduled for November 13, 2026, to consider stock split, bonus issue, and dividend proposals.
• Proposing up to 10-for-1 stock split, reducing share face value from Rs 10 to as low as Rs 1.
• Proposed bonus issue of up to 4:5, requiring approximately Rs 60.796 Cr capitalisation from other equity of Rs 61.805 Cr.
• Potential dividend of up to 100% (Rs 75.995 Cr) is unverified, with standalone cash at only Rs 0.1317 Cr as of September 30, 2026.

SC Agrotech Limited has received approval from the Ministry of Corporate Affairs for the incorporation of a wholly-owned subsidiary named SC Careoasis Healthcare Private Limited, incorporated on October 30, 2026. The new subsidiary has an authorized capital of ₹1,00,000 divided into 10,000 equity shares of ₹10 each, funded 100% via cash/banking channels. This move marks an entry into the pharmaceutical sector, diverging from SC Agrotech's primary business in dairy/agrotech products (which generated ₹124 Cr in TTM revenue). At an initial capital base of just ₹1 Lakh, the near-term financial commitment is negligible.

• Incorporated wholly-owned subsidiary SC Careoasis Healthcare Private Limited on October 30, 2026
• Target authorized capital is ₹1,00,000 divided into 10,000 equity shares of ₹10 each
• SC Agrotech holds 100% initial shareholding via cash/banking subscription
• Marks business diversification into the Pharma sector

SC Agrotech Ltd has postponed its Board Meeting originally scheduled for August 13, 2026, which was intended to discuss a potential stock split. The company cited "unavoidable circumstances" and the need for further consideration as reasons for the delay. A revised date for the meeting has not yet been announced. This postponement occurs in a micro-cap company with a market capitalization of Rs 79 Cr and a notable 0.0% promoter holding.

• Board meeting scheduled for August 13, 2026, has been postponed indefinitely.
• The meeting agenda included the proposal for a sub-division/split of existing equity shares.
• The company has not yet finalized a revised date for the rescheduled meeting.
• The initial intimation for this meeting was provided on August 10, 2026.

SC Agrotech Ltd has scheduled a board meeting for August 13, 2026, to consider and approve a split of its equity shares. The company is a micro-cap entity with a market capitalization of ₹82 Cr and TTM revenue of ₹88 Cr. A notable structural risk is the 0.0% promoter holding reported as of March 2026. The stock has experienced significant price appreciation, with a 128% return over the past 12 months, which may be driving the decision to improve liquidity through a split.

• Board meeting scheduled for August 13, 2026, to discuss a share split.
• Company reported TTM revenue of ₹88 Cr and a TTM PAT of ₹3 Cr.
• Promoter holding remains at 0.0% as of the latest March 2026 filing.
• Stock has delivered a 128.0% price return over the last 12 months.

SC Agrotech Ltd has scheduled a board meeting for August 10, 2026, to review and approve its unaudited financial results for the quarter ended June 30, 2026. The company, operating in the dairy products sector, reported a TTM revenue of Rs 88 Cr and a net profit of Rs 3 Cr. This meeting is critical for investors to assess if the high revenue growth seen in the March 2026 quarter (Rs 43.35 Cr) continues into the new fiscal year. Notably, the company maintains a 0.0% promoter holding, which is a significant structural detail for a Rs 90 Cr market cap firm.

• Board meeting scheduled for August 10, 2026, to approve Q1 FY27 results.
• Company reported TTM revenue of Rs 88 Cr against a market cap of Rs 90 Cr.
• Operating profit margin (OPM) stands at 5.3% as per latest TTM data.
• Promoter holding is currently 0.0% as of the March 2026 quarter.

SC Agrotech Ltd has responded to a clarification query from BSE regarding significant movement in its share price. The company stated on July 7, 2026, that there is no pending price-sensitive information or announcement that has not been disclosed to the exchange. Management attributes the recent price fluctuations to market-driven factors. This filing is a standard regulatory response to exchange-monitored volatility.

• BSE raised a query on June 29, 2026, regarding significant price movement in the company's security.
• Company issued a formal clarification on July 7, 2026, stating no pending material information exists.
• Management confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
• The filing was officially timestamped by the exchange on July 10, 2026.